COVID-19 Vaccine & Dermal Filler/Toxin Guidance

There have been industry lead conversations in regards to the COVID-19 vaccine and dermal filler administration. This is a result of findings from the FDA which stated that 3 individuals who had previously been administered with dermal fillers all experienced adverse reactions following the administration of the COVID-19 Moderna Vaccine. These findings were specific to the Moderna Vaccine (US vaccine) and not reported in either of the UK vaccines, AstraZeneca or Pfizer.

For dermal fillers, recent guidance issued by various aesthetics experts within the industry and aesthetics associations is to avoid administering dermal fillers two weeks before (at a minimum) or three weeks after (at a minimum) after the COVID-19 vaccination.

For toxins, there is currently no evidence that COVID-19 vaccination or infection has effects on other aesthetic procedures, including Botulinum Toxin. However, having reviewed industry guidance we suggest avoiding treatments for one week post vaccine, due to some patients becoming unwell and experiencing flu-like symptoms following vaccination.

For full guidance and details, please click here.

Disclaimer: The guidance and findings reported within this document are based on information gathered in March 2021. As information and guidance in regards to this matter will constantly be evolving, please refer to your professional regulator, aesthetic associations and the manufacturer for up-to-date guidance.